Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-061710

General Counsel and Secretary sold 2,112 shares at $52.58 ($111,049)

  • General Counsel and Secretary acquired 3,825 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Exercise or conversion : show line 1 in the form +3,825 87,227 D
2026-02-19 Sale : show line 2 in the form −2,112 $52.58 $111,049 85,115 D
Open-market sales · 2,112 sh · avg $52.58 · $111,049

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,825 0 D
Loading xslF345X05/ownership.xml…